Maixnerova, D.; El Mehdi, D.; Rizk, D.V.; Zhang, H.; Tesar, V.
New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies. J. Clin. Med. 2022, 11, 2810.
https://doi.org/10.3390/jcm11102810
AMA Style
Maixnerova D, El Mehdi D, Rizk DV, Zhang H, Tesar V.
New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies. Journal of Clinical Medicine. 2022; 11(10):2810.
https://doi.org/10.3390/jcm11102810
Chicago/Turabian Style
Maixnerova, Dita, Delphine El Mehdi, Dana V. Rizk, Hong Zhang, and Vladimir Tesar.
2022. "New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies" Journal of Clinical Medicine 11, no. 10: 2810.
https://doi.org/10.3390/jcm11102810
APA Style
Maixnerova, D., El Mehdi, D., Rizk, D. V., Zhang, H., & Tesar, V.
(2022). New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies. Journal of Clinical Medicine, 11(10), 2810.
https://doi.org/10.3390/jcm11102810